These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27743074)

  • 1. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
    Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
    Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
    Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
    Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
    Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.
    Wang Y; Ren Z; Shen YH; Fang XG; Li QL; Zhong YS; Zhang YQ; Chen WF; Zhou PH; Lin SL
    Gastrointest Endosc; 2024 Sep; 100(3):481-491.e6. PubMed ID: 38431107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.
    Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
    Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
    J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.
    Kachare SD; Liner KR; Vohra NA; Zervos EE; Fitzgerald TL
    Am Surg; 2014 Aug; 80(8):821-6. PubMed ID: 25105406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
    J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
    Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.
    Vanoli A; Albarello L; Uncini S; Fassan M; Grillo F; Di Sabatino A; Martino M; Pasquali C; Milanetto AC; Falconi M; Partelli S; Doglioni C; Schiavo-Lena M; Brambilla T; Pietrabissa A; Sessa F; Capella C; Rindi G; La Rosa S; Solcia E; Paulli M
    Am J Surg Pathol; 2019 Jun; 43(6):725-736. PubMed ID: 30913089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.